BioSpace News Archive

Pharm Country

Acurx to present at the 42nd Annual J.P. Morgan Healthcare Conference

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”) today announced that President and Chief Executive Officer David P. Luci will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024 at 12:00 pm PST.

January 3, 2024
·
1 min read
Pharm Country

CSL Behring Announces Availability of Hizentra® (Immune Globulin Subcutaneous [Human] 20% Liquid) 10g Prefilled Syringe

CSL Behring today announced the availability of a 10g prefilled syringe for Hizentra® (Immune Globulin Subcutaneous [Human] 20% Liquid).

January 3, 2024
·
8 min read
Biotech Bay

BioMarin to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, at 10:30 am PT / 1:30 pm ET, in San Francisco, CA

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy , President and Chief Executive Officer of BioMarin, will present at the 42nd Annual J.P. Morgan Conference on Monday January 8, 2024 , at 10:30 am PT / 1:30 pm ET , in San Francisco, California.

January 3, 2024
·
1 min read
Drug Development

Intensity Therapeutics Provides Business Update Reflecting Progress in Phase 3 Sarcoma Program

Intensity Therapeutics, Inc. today announced a business update reflecting progress in its phase 3 sarcoma clinical program.

January 3, 2024
·
8 min read
Pharm Country

Avantor® to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

Avantor, Inc. announced that Michael Stubblefield , President and CEO, will present at the 42nd Annual J.P. Morgan Healthcare Conference at The Westin St. Francis Hotel in San Francisco.

January 3, 2024
·
1 min read
Biotech Beach

OGM Added to International System for Human Cytogenomic Nomenclature

Bionano Genomics, Inc., announced a publication outlining the addition of optical genome mapping to the International System for Human Cytogenomic Nomenclature.

January 3, 2024
·
5 min read
Deals

Entera Bio Receives Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule

Entera Bio Ltd. announced that, on December 27, 2023, it received an extension of 180 calendar days from the Nasdaq Stock Market LLC (“Nasdaq”) to regain compliance with the Nasdaq’s minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2).

January 3, 2024
·
6 min read
Business

HEALTH CANADA APPROVES PFIZER CANADA’S GENE THERAPY IN HEMOPHILIA B

Pfizer Canada ULC announced that Health Canada approved BEQVEZ (fidanacogene elaparvovec), an adeno-associated viral (AAV) vector-based gene therapy for the treatment of adults (aged 18 years or older) with moderately severe to severe hemophilia B.

January 3, 2024
·
4 min read
BioMidwest

On Target Laboratories Names Scott Huennekens as Executive Chairperson of the Board

On Target Laboratories, Inc. announced the appointment of Scott Huennekens as Executive Chairperson of the Board.

January 3, 2024
·
2 min read
Genetown

Sionna Therapeutics to Present Updates on Clinical Progress in Cystic Fibrosis at 42nd Annual J.P. Morgan Healthcare Conference

Sionna Therapeutics to Present Updates on Clinical Progress in Cystic Fibrosis at 42nd Annual J.P. Morgan Healthcare Conference.

January 3, 2024
·
4 min read